American Healthcare REIT, Inc. (NYSE:AHR) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of American Healthcare REIT, Inc. (NYSE:AHR) have earned a consensus recommendation of “Moderate Buy” from the eight research firms that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $26.00.

AHR has been the subject of several recent analyst reports. Royal Bank of Canada increased their price objective on shares of American Healthcare REIT from $28.00 to $30.00 and gave the stock an “outperform” rating in a research report on Monday, November 18th. Truist Financial increased their price objective on shares of American Healthcare REIT from $27.00 to $29.00 and gave the stock a “buy” rating in a research report on Friday, November 15th. Colliers Securities raised shares of American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research note on Sunday, October 13th. Finally, Morgan Stanley increased their target price on shares of American Healthcare REIT from $27.00 to $29.00 and gave the stock an “overweight” rating in a research note on Monday, December 30th.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. GAMMA Investing LLC lifted its stake in shares of American Healthcare REIT by 104.1% in the fourth quarter. GAMMA Investing LLC now owns 988 shares of the company’s stock valued at $28,000 after buying an additional 504 shares in the last quarter. Carolina Wealth Advisors LLC bought a new position in shares of American Healthcare REIT during the fourth quarter valued at about $29,000. Wilmington Savings Fund Society FSB bought a new position in shares of American Healthcare REIT during the third quarter valued at about $28,000. Kozak & Associates Inc. bought a new position in shares of American Healthcare REIT during the third quarter valued at about $28,000. Finally, Quarry LP bought a new position in shares of American Healthcare REIT during the third quarter valued at about $33,000. 16.68% of the stock is owned by institutional investors.

American Healthcare REIT Trading Down 4.1 %

Shares of NYSE AHR opened at $28.41 on Thursday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.37 and a current ratio of 0.37. American Healthcare REIT has a 52-week low of $12.63 and a 52-week high of $29.99. The firm has a 50 day moving average price of $28.37 and a two-hundred day moving average price of $24.48. The stock has a market cap of $4.35 billion and a P/E ratio of -59.19.

American Healthcare REIT (NYSE:AHR) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.35). American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.87%. The business had revenue of $523.81 million during the quarter, compared to analyst estimates of $474.26 million. The business’s quarterly revenue was up 12.8% on a year-over-year basis. As a group, equities analysts forecast that American Healthcare REIT will post 1.41 EPS for the current year.

American Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.52%. The ex-dividend date of this dividend was Tuesday, December 31st. American Healthcare REIT’s dividend payout ratio (DPR) is -208.33%.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.